03 Recovery Research Compounds of interest in recovery-pathway research and cellular studies
Research outcomes should not be extrapolated to expected human results
As peptides return to licensed compounding, prescribers must ensure theyre ordering from pharmacies that can document their entire supply chain, not pharmacies that pivot to peptides opportunistically without the infrastructure to handle them safely
April 15, 2026: In the updated 503A document, the FDA announced it is removing BPC-157 (both BPC-157 acetate and BPC-157 free base) from Category 2 and scheduling a PCAC meeting for July 23, 2026
Sikiric assured me that the trial had been absolutely successful and that the data would be available very soon, but he declined to let me see it
Protocols That Work: How to Use BPC-157 for Arthritis Most clients want to know what a typical protocol looks like